Compare Agilent Technologies Inc (A) vs Prologis Inc (PLD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Prologis Inc — how do they compare? Agilent Technologies Inc trades at $128.42 (market cap $37.04B), while Prologis Inc trades at $141.39 (market cap $133.89B). The key difference: Prologis Inc is far larger — about 3.6× Agilent Technologies Inc's market cap, and Prologis Inc pays the higher dividend (2.98%). Which is the better fit depends on your goals.
| A | PLD | |
|---|---|---|
Market Cap | $37.04B | $133.89B |
Sector | Health | Real Estate |
52-Week High | $157.20 | $148.74 |
52-Week Low | $110.24 | $104.08 |
Enterprise Value | $38.59B | $167.77B |
Dividend Yield | 0.78% | 2.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Prologis (PLD) trades at $143.61, up 2.98% in the last session, with a bullish technical signal and consistent earnings beats. The stock shows strong fundamentals with a 41.54% net income margin and a $1.07 dividend payment scheduled for June 30, 2026. Recent news highlights a rejected $16.6 billion takeover bid for Segro, indicating aggressive growth ambitions. Cash flow trends remain volatile, with 2025 net cash flow negative at -$172.94 million, though operating cash flow stays robust at $5.01 billion.
Outlook is positive with a consensus price target of $155.20, offering 8% upside. Risks include rising debt-to-asset ratio (37.2% in 2025) and macroeconomic sensitivity. The bullish analyst consensus (57% buy ratings) supports growth from data center expansion and rent spreads, but investors should monitor leverage and acquisition integration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
